Berna Demir Yuksel

Berna Demir Yuksel

Auto-generated profile, based on publicly available information

Berna Demir Yuksel

Department of Endocrinology and Metabolism, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Turkish Journal of Pathology
Verified
Journal Article
Open access
CHCihan Heybeli
Cihan Heybeli
BYBerna Demir Yuksel
Berna Demir Yuksel
MUMehtat Unlu
Mehtat Unlu
MOMehmet Asi Oktan
Mehmet Asi Oktan
HAHayri Ustun Arda
Hayri Ustun Arda
SSSulen Sarioglu
Sulen Sarioglu
Objective: Granulomatous interstitial nephritis is a rare finding, and etiology differs by geography. We aimed to investigate the distribution of causes of granuloma/granulomata in the kidney and renal survival of these patients in a tertiary care hospital in Western Turkey.

30 December 2024 in Clinical Endocrinology
Verified
Journal Article
Closed access
ÜÇÜmit Çavdar
Ümit Çavdar
DKDerya Sema Yaman Kalender
Derya Sema Yaman Kalender
BYBerna Demir Yüksel
Berna Demir Yüksel
BPBarış Önder Pamuk
Barış Önder Pamuk
AÇAbdurrahman Çömlekçi
Abdurrahman Çömlekçi
SYSerkan Yener
Serkan Yener

3 August 2026 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
BSBasak Ozgen Saydam
Basak Ozgen Saydam
ISILGIN YILDIRIM SIMSIR
ILGIN YILDIRIM SIMSIR
BYBerna Demir Yuksel
Berna Demir Yuksel
CACanan Altay
Canan Altay
NYNusret Yilmaz
Nusret Yilmaz
BABaris Akinci
Baris Akinci

26 October 2026 in Developments and Experiments in Health and Medicine
Verified
Journal Article
Closed access
GSGökçen Güngör Semiz
Gökçen Güngör Semiz
MUmehmet cagri Unal
mehmet cagri Unal
BYBerna Demir Yuksel
Berna Demir Yuksel
MGMerve Celik Guler
Merve Celik Guler
GYGülsüm Ceren Terzioğlu Yazıcı
Gülsüm Ceren Terzioğlu Yazıcı
SYSerkan Yener
Serkan Yener
Background:This study examines the prognostic role of diabetes mellitus (DM) in predicting COVID-19 severity and fatal outcomes among hospitalized patients in Turkey. By evaluating a large cohort, we aim to delineate the relationship between DM and ICU utilization and to validate our findings against Turkish national data. Methods:This retrospective study analyzed 906 patients hospitalized with confirmed COVID-19 between 2020 and 2021. Patients were categorized into diabetic and non-diabetic groups. Age- and sex-matched analyses were conducted to isolate the effect of DM on ICU admission rates, oxygen requirements, length of stay (LOS), and in-hospital mortality. Results: Diabetic patients experienced significantly more severe illness compared to non-diabetics. They demonstrated markedly higher rates of ICU admission (OR=1.474, 95% CI: 1.038–2.094; p=0.030) and oxygen supplementation needs (p < 0.05). LOS was significantly longer in the diabetic group (p <0.05). While the mortality rate was clinically higher in diabetic patients (16.9% vs. 15.9%), the difference was not statistically significant. Advanced age (≥65 years), male sex, and hypertension were identified as primary predictors of severity. Conclusion: Our findings confirm that DM is a primary driver of COVID-19 severity and resource utilization in Turkey, consistent with the national 'TurCoviDia' study. The increased need for ICU care and respiratory support underscores the necessity for early clinical intervention and rigorous glycemic management to improve prognostic outcomes.